Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response

References

• R L S, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–12. doi:10.3322/caac.21254.
   PubMed Web of Science ®Google Scholar
• Liao L, Song M, Li X, Tang L, Zhang T, Zhang L, Pan Y, Chouchane L, Ma X. E3 ubiquitin ligase UBR5 drives the growth and metastasis of triple negative breast cancer. Cancer Res. 2017;77:2090–2101. doi:10.1158/0008-5472.CAN-16-2409.
   PubMed Web of Science ®Google Scholar
• M J C, Russell AJ, Woollatt E, Sutherland GR, Sutherland RL, Watts CK. Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene. 1998;17:3479–3491. doi:10.1038/sj.onc.1202249.
   PubMed Web of Science ®Google Scholar
• D N S, Hird SL, Withington SL, Dunwoodie SL, Henderson MJ, Biben C, Sutherland RL, Ormandy CJ, Watts CK. Edd, the murine hyperplastic disc gene, is essential for yolk sac vascularization and chorioallantoic fusion. Mol Cell Biol. 2004;24:7225–7234. doi:10.1128/MCB.24.16.7225-7234.2004.
   PubMed Web of Science ®Google Scholar
• Kinsella E, Dora N, Mellis D, Lettice L, Deveney P, Hill R, Ditzel M. Use of a conditional Ubr5 mutant allele to investigate the role of an N-end rule ubiquitin-protein ligase in hedgehog signalling and embryonic limb development. PLoS One. 2016;11:e0157079. doi:10.1371/journal.pone.0157079.
   PubMed Web of Science ®Google Scholar
• R F S, Frikstad KM, McKenna J, McCloy RA, Deng N, Burgess A, Stokke T, Patzke S, Saunders DN. The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia. Mol Biol Cell. 2018:mbcE17040248. doi:10.1091/mbc.E17-04-0248.
   Web of Science ®Google Scholar
• Koyuncu S, Saez I, Lee HJ, Gutierrez-Garcia R, Pokrzywa W, Fatima A, Hoppe T, Vilchez D. The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington’s disease patients. Nat Commun. 2018;9:2886. doi:10.1038/s41467-018-05320-3.
   PubMed Web of Science ®Google Scholar
• J L C, Henderson MJ, Russell AJ, Anderson DW, Bova RJ, Campbell IG, Choong DY, Macdonald GA, Mann GJ, Nolan T, et al. EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene. 2003;22:5070–5081. doi:10.1038/sj.onc.1206775.
   PubMed Web of Science ®Google Scholar
• D R R, Wu YM, Lonigro RJ, Vats P, Cobain E, Everett J, Cao X, Rabban E, Kumar-Sinha C, Raymond V, et al. Integrative clinical genomics of metastatic cancer. Nature. 2017;548:297–303. doi:10.1038/nature23306.
   PubMed Web of Science ®Google Scholar
• D S C, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, UALCAN: VS. A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, NY). 2017;19:649–658. doi:10.1016/j.neo.2017.05.002.
   PubMed Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, et al. An integrated TCGA Pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173:400–416.e411. doi:10.1016/j.cell.2018.02.052.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21. doi:10.1093/bioinformatics/bts635.
   PubMed Web of Science ®Google Scholar
• Anders S, Pyl PT, Huber W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166–169. doi:10.1093/bioinformatics/btu638.
   PubMed Web of Science ®Google Scholar
• M I L, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi:10.1186/s13059-014-0550-8.
   PubMed Web of Science ®Google Scholar
• Kramer A, Green J, Pollard J Jr., Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523–530. doi:10.1093/bioinformatics/btt703.
   PubMed Web of Science ®Google Scholar
• Dompe N, Rivers CS, Li L, Cordes S, Schwickart M, Punnoose EA, Amler L, Seshagiri S, Tang J, Modrusan Z, et al. A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis. Proc Natl Acad Sci U S A. 2011;108:E943–951. doi:10.1073/pnas.1100132108.
   PubMed Web of Science ®Google Scholar
• Stankic M, Pavlovic S, Chin Y, Brogi E, Padua D, Norton L, Massague J, Benezra R. TGF-beta-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition. Cell Rep. 2013;5:1228–1242. doi:10.1016/j.celrep.2013.11.014.
   PubMed Web of Science ®Google Scholar
• Kong Y, Cao W, Xi X, Ma C, Cui L, He W. The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D. Blood. 2009;114:310–317. doi:10.1182/blood-2008-12-196287.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhou L, Zong J, Ye Y, Chen G, Chen Y, Liao X, Guo Q, Qiu S, Lin S, et al. Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma. Oncotarget. 2017;8:42007–42019. doi:10.18632/oncotarget.14917.
   PubMedGoogle Scholar
• Cho H, Chung JY, Kim S, Braunschweig T, Kang TH, Kim J, Chung EJ, Hewitt SM, Kim JH. MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer. BMC Cancer. 2014;14:957. doi:10.1186/1471-2407-14-957.
   PubMed Web of Science ®Google Scholar
• M A M, Saunders DN, Henderson MJ, Clancy JL, Russell AJ, Lehrbach G, Musgrove EA, Watts CK, Sutherland RL. The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints. Cell Cycle. 2007;6:3070–3077. doi:10.4161/cc.6.24.5021.
   PubMed Web of Science ®Google Scholar
• Smits VA. EDD induces cell cycle arrest by increasing p53 levels. Cell Cycle. 2012;11:715–720. doi:10.4161/cc.11.4.19154.
   PubMed Web of Science ®Google Scholar
• Ling S, Lin WC. EDD inhibits ATM-mediated phosphorylation of p53. J Biol Chem. 2011;286:14972–14982. doi:10.1074/jbc.M110.182527.
   PubMed Web of Science ®Google Scholar
• Li J, Yang Z, Chen Z, Bao Y, Zhang H, Fang X, Yang W. ATF3 suppresses ESCC via downregulation of ID1. Oncol Lett. 2016;12:1642–1648. doi:10.3892/ol.2016.4832.
   PubMed Web of Science ®Google Scholar
• San-Marina S, Han Y, Suarez Saiz F, Trus MR, Minden MD. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes. Biochim Biophys Acta. 2008;1783:503–517. doi:10.1016/j.bbamcr.2007.11.015.
   PubMed Web of Science ®Google Scholar